Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data
Meta-analysis / review
Abstract
This assessment reviews the in-vitro, preclinical, pharmacokinetic and clinical data on Boswellia serrata gum-resin extract, supporting its anti-inflammatory use for inflammatory bowel disease, arthritis and asthma as a better-tolerated alternative to NSAIDs.
Referenced for these plants
How to cite
Abdel-Tawab, M., Werz, O. and Schubert-Zsilavecz, M (2011) 'Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data', Clinical Pharmacokinetics, 50(6), pp. 349-369. doi:10.2165/11586800-000000000-00000
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.